These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23252240)

  • 21. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.
    Fartoux L; Poujol-Robert A; Guéchot J; Wendum D; Poupon R; Serfaty L
    Gut; 2005 Jul; 54(7):1003-8. PubMed ID: 15951550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of patients with hepatosteatosis and chronic hepatitis C.
    Smoliński P; Pazgan-Simon M; Zuwała-Jagiełło J; Hałoń A; Rotter K; Gładysz A
    Przegl Epidemiol; 2008; 62(3):571-9. PubMed ID: 19108521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C genotype 3 disease.
    Kattakuzhy S; Levy R; Rosenthal E; Tang L; Wilson E; Kottilil S
    Hepatol Int; 2016 Nov; 10(6):861-870. PubMed ID: 27328848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.
    Liu CJ; Chen PJ; Jeng YM; Huang WL; Yang WS; Lai MY; Kao JH; Chen DS
    J Hepatol; 2005 Aug; 43(2):235-42. PubMed ID: 15964656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
    El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histomorphological changes in hepatitis C non-responders with respect to viral genotypes.
    Adnan U; Mirza T; Aziz S; Naz E
    J Pak Med Assoc; 2013 Apr; 63(4):448-53. PubMed ID: 23905439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms and significance of liver steatosis in hepatitis C virus infection.
    Negro F
    World J Gastroenterol; 2006 Nov; 12(42):6756-65. PubMed ID: 17106922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steatosis and insulin resistance in response to treatment of chronic hepatitis C.
    Negro F
    J Viral Hepat; 2012 Jan; 19 Suppl 1():42-7. PubMed ID: 22233413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adiponectin changes in HCV-Genotype 4: relation to liver histology and response to treatment.
    Derbala M; Rizk N; Al-Kaabi S; Amer A; Shebl F; Al Marri A; Aigha I; Alyaesi D; Mohamed H; Aman H; Basem N
    J Viral Hepat; 2009 Oct; 16(10):689-96. PubMed ID: 19486470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C.
    Baranova A; Jarrar MH; Stepanova M; Johnson A; Rafiq N; Gramlich T; Chandhoke V; Younossi ZM
    Digestion; 2011; 83(1-2):32-40. PubMed ID: 20847561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C and steatosis.
    Björnsson E; Angulo P
    Arch Med Res; 2007 Aug; 38(6):621-7. PubMed ID: 17613353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes.
    Hnatyszyn HJ
    Antivir Ther; 2005; 10(1):1-11. PubMed ID: 15751759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis.
    Nkontchou G; Ziol M; Aout M; Lhabadie M; Baazia Y; Mahmoudi A; Roulot D; Ganne-Carrie N; Grando-Lemaire V; Trinchet JC; Gordien E; Vicaut E; Baghad I; Beaugrand M
    J Viral Hepat; 2011 Oct; 18(10):e516-22. PubMed ID: 21914071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of naive patients with chronic hepatitis C].
    Vince A; Duvnjak M
    Acta Med Croatica; 2009 Dec; 63(5):409-15. PubMed ID: 20198900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C Genotype 3 Infection: Pathogenesis and Treatment Horizons.
    Maddur H; Flamm SL
    Clin Liver Dis; 2017 Nov; 21(4):645-657. PubMed ID: 28987253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocyte steatosis is an important predictor of response to interferon (IFN) monotherapy in Japanese patients infected with HCV genotype 2a: Virological features of IFN-resistant cases with hepatocyte steatosis.
    Akuta N; Suzuki F; Suzuki Y; Sezaki H; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
    J Med Virol; 2005 Apr; 75(4):550-8. PubMed ID: 15714492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between histological findings, aminotransferase levels and viral genotype in chronic hepatitis C infection.
    Fecury AA; Almeida MK; Santos KN; Freitas Ada S; Dantas Sde F; Costa CA; Crescente ÂB; Sousa RC; Brito EB; Nassiri R; Lampe E; Martins LC
    Rev Soc Bras Med Trop; 2014; 47(1):90-2. PubMed ID: 24553802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.